Chembio to buy Brazilian point-of-care diagnostics company Orangelife
The acquisition of Orangelife will help Chembio to expand its commercial presence in Brazil
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Nov 19
The acquisition of Orangelife will help Chembio to expand its commercial presence in Brazil
08 Nov 19
Physicians can use the new cheek swab to screen patients with COPD for alpha-1 antitrypsin deficiency (Alpha-1)
08 Nov 19
SANUWAVE Health is a shockwave technology company initially focused on the development and commercialization of patented noninvasive, biological…
08 Nov 19
Allen Technologies, the pioneer of interactive patient engagement solutions for 40 years, transforms the way hospitals engage, educate…
07 Nov 19
The new procedure marks a pivotal step in implementation of robotics to address neurovascular disease
07 Nov 19
Vela Diagnostics has developed Sentosa SQ HIV-1 Genotyping Assay for detecting HIV-1 drug resistance mutations (DRMs)
07 Nov 19
MEDx and Lucence announced a strategic partnership in China to co-develop cancer-care tests
07 Nov 19
Penumbra Indigo Aspiration System is a continuous mechanical thrombectomy system that removes blood clots from the arteries and…
07 Nov 19
The Early Bird Bleed Monitoring System includes a bleed detection array with integrated electrodes in a fully functional…
07 Nov 19
FDA-cleared single-use endoscope technology for arthroscopic surgical procedures to undergo rollout of global distribution